Peripheral Vascular Disease (PVD) Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Impact of a quality improvement initiative on medical management of Veterans with peripheral artery disease
Peripheral artery disease (PAD) is a leading cause of atherosclerotic cardiovascular morbidity and is associated with increased rates of lower extremity amputation (LEA).1 PAD is a strong predictor of both cardiovascular and overall mortality, even more so than prior MI.2,3 In fact, PAD in the absence of known CAD predicted cardiovascular events more strongly than did CAD.4 (Source: The American Journal of Cardiology)
Source: The American Journal of Cardiology - April 16, 2024 Category: Cardiology Authors: Lawrence Hoang, Bidyut Mani, Gina Wilson, Jenifer Chisom Ogu, Subhash Banerjee, Bala Ramanan, J. Gregory Modrall, Carlos H. Timaran, Shirling Tsai Source Type: research

Impact of atrial fibrillation on 1-year outcome in patients with implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator: results from the German DEVICE Registry
CONCLUSIONS: Our clinical data on an extended cohort of contemporary patients confirm the significant impact of AF, and its associated comorbidities, upon mortality and major adverse events after implantation of ICD/CRT.PMID:38617758 | PMC:PMC11009579 | DOI:10.21037/jtd-23-274 (Source: Journal of Thoracic Disease)
Source: Journal of Thoracic Disease - April 15, 2024 Category: Respiratory Medicine Authors: Sebastian Feickert Niels Christian Ewertsen Julia K öbe Thomas Kleemann Joachim Jehle Jochen Senges Matthias Hochadel Dietrich Andresen Christoph Stellbrink Lars Eckardt Stefan Spitzer Johannes Brachmann H üseyin Ince Giuseppe D'Ancona Source Type: research

Beyond Venoarterial and Venovenous ECMO: Novel Cannulation Strategies
Extracorporeal Membrane Oxygenation (ECMO) is most commonly used as either lung support or venovenous ECMO (VV-ECMO) or combined heart and lung support or venoarterial ECMO (VA-ECMO). In certain instances such as large body habitus, peripheral vascular disease or poor vascular access, these strategies may not provide sufficient support or are not feasible to deploy. New strategies for ECMO including parallel VV-ECMO circuits for patients with high cardiac output, veno-venopulmonary ECMO, left atrial venoarterial ECMO, and dual lumen cannula access through the left ventricular apical may be helpful in complex circumstances....
Source: Journal of Cardiothoracic and Vascular Anesthesia - April 15, 2024 Category: Anesthesiology Authors: Anthony Calhoun, Christopher Szabo, David Convissar, Dominic V. Pisano, Jamel Ortoleva Tags: Editorial Source Type: research

Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease: an observational, register-based cohort study
Type 2 diabetes (T2D) and peripheral artery disease (PAD) are recognized as independent risk factors contributing to excess mortality. Contemporary observational studies exploring the associations of risk fact... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - April 15, 2024 Category: Cardiology Authors: Tarik Avdic, Hanne K. Carlsen, Aidin Rawshani, Soffia Gudbj örnsdottir, Zacharias Mandalenakis and Björn Eliasson Tags: Research Source Type: research

Cardiovascular risk and inflammation in a population with autoimmune diseases: a narrative review
Front Immunol. 2024 Mar 28;15:1380372. doi: 10.3389/fimmu.2024.1380372. eCollection 2024.ABSTRACTJuvenile Systemic Connective Tissue Diseases (JSCTD) are a heterogeneous group of chronic autoimmune diseases, associated with dyslipidemia and increased cardiovascular risk are related. Studies from the last 10 years, from 2013 to 2022, on lipid profiles in JSCTD were collected. Different studies on lipid profiles in children affected by JSCTD were selected, because the aim is to analyze the cardiovascular risk and the possibility of atherosclerosis in these patients in whom, sometimes, corticosteroid therapies and immunosuppr...
Source: Atherosclerosis - April 12, 2024 Category: Cardiology Authors: Camilla Bertoni Alessandra Mazzocchi Ludovica Leone Carlo Agostoni Giovanni Filocamo Source Type: research

Reversion of the Inflammatory Markers in Patients With Chronic Limb-Threatening Ischemia
CONCLUSIONS: CLTI has an inflammatory environment that can be partially reverted after resolution of the ischemic process, emphasizing the importance of timely intervention.PMID:38606780 | DOI:10.1161/JAHA.123.031922 (Source: Atherosclerosis)
Source: Atherosclerosis - April 12, 2024 Category: Cardiology Authors: Joana Ferreira Susana Roque Alexandre Lima Carneiro Adhemar Longatto-Filho Isabel Vila Cristina Cunha Cristina Silva Am ílcar Mesquita Jorge Cotter Margarida Correia-Neves Armando Mansilha Pedro Guimar ães Cunha Source Type: research